Prader-Willi Syndrome (PWS) Market is segmented By Growth Hormone Therapy (GENOTROPIN, NORDITROPIN, ...
Market Size in USD Bn
CAGR7.2%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 7.2% |
Market Concentration | High |
Major Players | Soleno Therapeutics, Harmony Biosciences, Pfizer, Novo Nordisk, Sandoz and Among Others |
The Prader-Willi Syndrome (PWS) market is estimated to be valued at USD 0.98 Bn in 2025 and is expected to reach USD 1.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.
Increase in research funding for developing new and improved treatment options for PWS is a key factor driving the market. Several clinical trials evaluating the safety, efficacy of new treatment approaches such as restriction of calorie intake, growth hormone supplementation, and behavior therapy are currently underway.